ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,230Medicare Part D Prescriptions Filled, Including Refills

Rank: 139 out of 2456

$621K Total Retail Price of All Prescriptions

Rank: 147 out of 2456

502 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 502 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 502 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 8,821 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 628 542 1 1
ATORVASTATIN CALCIUM 403 355 2 12
FUROSEMIDE 393 350 3 8
ATENOLOL 384 362 4 6
METOPROLOL TARTRATE 362 308 5 10
HYDROCHLOROTHIAZIDE 272 249 6 7
SIMVASTATIN 267 226 7 2
HYDROCODONE-ACETAMINOPHEN 257 148 S3 8 20
LEVOTHYROXINE SODIUM 251 227 9 4
WARFARIN SODIUM 224 186 10 9
CITALOPRAM HBR 214 171 11 14
AMLODIPINE BESYLATE 201 197 12 5
PRAVASTATIN SODIUM 189 121 13 15
OMEPRAZOLE 183 145 14 3
GABAPENTIN 163 100 15 16
TERAZOSIN HCL 156 156 16 76
LORAZEPAM 148 131 17 67
METFORMIN HCL 146 129 18 11
PROAIR HFA 146 83 18 22
TRAMADOL HCL 140 61 20 24
OXYCODONE-ACETAMINOPHEN 140 100 S2 20 35
NIFEDIAC CC 134 117 22 175
IBUPROFEN 130 42 23 52
WELCHOL 123 111 24 304
ALENDRONATE SODIUM 105 101 25 19
ALLOPURINOL 103 93 26 27
TAMSULOSIN HCL 103 92 26 32
DOXAZOSIN MESYLATE 96 89 28 71
ACETAMINOPHEN-CODEINE 92 31 S3 29 106
DONEPEZIL HCL 92 92 29 23
GLIPIZIDE 91 77 31 46
TRAZODONE HCL 87 56 32 17
LOVASTATIN 84 68 33 34
BACLOFEN 83 52 34 112
ZETIA 78 63 35 86
MORPHINE SULFATE ER 78 0 S2 35 98
FINASTERIDE 76 69 37 66
DIOVAN 74 70 38 26
DIFLUNISAL 74 52 38 426
DIGOXIN 73 73 40 49
AMITRIPTYLINE HCL 70 24 R 41 83
QVAR 64 60 42 197
LESCOL XL 64 60 10 42 351
CLOPIDOGREL 62 49 44 55
MORPHINE SULFATE 60 0 S2 45 226
RANITIDINE HCL 59 50 46 31
NAMENDA 57 57 47 42
SERTRALINE HCL 55 38 48 21
FLUNISOLIDE 55 37 48 341
BUPROPION HCL 55 35 48 210
FLUVASTATIN SODIUM 54 54 10 51 377
ALPRAZOLAM 54 54 51 141
IPRATROPIUM BROMIDE 54 44 51 273
PAROXETINE HCL 53 45 54 56
CLEMASTINE FUMARATE 53 31 R 54 365
CYCLOBENZAPRINE HCL 52 39 R 56 77
FENTANYL 51 24 S2 57 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.